Empirical Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Empirical Asset Management's AMGN Position: Q2 2026 in Review
Empirical Asset Management increased its Amgen (AMGN) stake by 92% in Q2 2026, buying an estimated $480K and bringing the position to 2,925 shares worth $1.06M. The position accounts for 0.24% of the portfolio, ranked #113.
Empirical Asset Management first reported a position in AMGN in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.19M in Q2 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Empirical Asset Management held 2,925 shares of Amgen worth $1.06M as of Q2 2026.
- Empirical Asset Management bought 1,403 Amgen shares in Q2 2026, an estimated $480K.
- Amgen made up 0.24% of Empirical Asset Management's portfolio in Q2 2026, its #113 holding.
- Empirical Asset Management first reported a position in Amgen in Q2 2023 and has held it in 10 quarters since.
- Empirical Asset Management's Amgen position peaked at $1.19M in Q2 2025.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.